Related Experiment Videos
Matrix metalloproteinases and their inhibitors in acute viral hepatitis
M Koulentaki1, V Valatas, K Xidakis
1Department of Gastroenterology, University Hospital of Heraklion Crete, Crete, Greece.
Abstract:
Matrix metalloproteases (MMPs) and their inhibitors are effector molecules involved in extracellular matrix remodelling. The serum profile for these proteolytic enzymes and their inhibitors during acute self-limiting viral hepatitis has not been studied. We therefore determined serum concentrations of MMP-1, MMP-3, MMP-2, MMP-9 and their inhibitors (tissue inhibitors of metalloproteinase) TIMP-1, TIMP-2 and alpha2 macroglobulin (AMG) in the serum of patients during the icteric stage of self-limiting acute viral hepatitis. Transforming growth factor-beta (TGF-beta) and interleukin (IL)-10, two cytokines involved in the regulation of MMPs and TIMPs were also assessed. Nineteen patients (12 men, seven women) with a mean age of 29.9 years (range 16-65 years) participated in the study. Fifteen had hepatitis B virus (HBV, two HCV and two HAV infection. The values of patients were compared with those obtained from 15 blood donor controls (eight men, seven women), mean age 36.2 years (range 18-55 years). Serum levels of TGF-beta, IL-10, MMP-1, MMP-3, MMP-2, MMP-9, TIMP-1 and TIMP-2 were assessed by ELISA. MMP-2 and MMP-9 were also measured by a zymogram protease assay. alpha2 macroglobulin (AMG) was measured by nephelometry. Compared with the healthy controls the mean serum concentrations of all MMPs were significantly decreased in the acute hepatitis patients. There was no difference in the serum concentration of TIMP-1 between patients and the controls. Serum levels of TIMP-2 (P < 0001), TGF-beta (P < 0.05), IL-10 (P < 0.001) and AMG (P < 0001) were increased in patients compared to healthy controls. A statistically significant negative correlation by linear regression analysis was found between AMG and MMP-1 (P=0003). The decreased levels of MMPs observed, together with normal and increased levels of TIMP-1 and TIMP-2, may indicate an attempt to limit matrix degradation at this stage of disease resolution. The increased levels of the anti-inflammatory cytokines IL-10 and TGF-beta might be the underlying mechanism responsible for the above effect. AMG inhibition especially for MMP-1 may play an additional important role.
Insights
Serum matrix metalloproteinases (MMPs) were decreased in acute viral hepatitis patients. Increased levels of MMP inhibitors like alpha2 macroglobulin (AMG) and cytokines suggest a mechanism to limit matrix degradation during disease resolution.
Area of Science:
- Biochemistry
- Immunology
- Hepatology
Background:
- Matrix metalloproteinases (MMPs) and their inhibitors (TIMPs, AMG) are key in extracellular matrix remodeling.
- Serum profiles of these molecules in acute viral hepatitis are not well-established.
- Cytokines like TGF-beta and IL-10 regulate MMPs and TIMPs.
Purpose of the Study:
- To determine serum concentrations of MMPs (MMP-1, -3, -2, -9) and their inhibitors (TIMP-1, -2, AMG) during acute viral hepatitis.
- To assess serum levels of TGF-beta and IL-10 in these patients.
- To compare these levels with healthy controls and investigate correlations.
Main Methods:
- Serum samples from 19 acute viral hepatitis patients (HBV, HCV, HAV) and 15 healthy controls were analyzed.
- ELISA was used for TGF-beta, IL-10, MMP-1, -3, -2, -9, TIMP-1, and TIMP-2.
- Zymography measured MMP-2 and MMP-9 activity; nephelometry measured AMG.
Main Results:
- All MMPs (MMP-1, -3, -2, -9) were significantly decreased in patients compared to controls.
- TIMP-1 levels showed no difference, while TIMP-2, AMG, TGF-beta, and IL-10 were significantly increased in patients.
- A negative correlation was found between AMG and MMP-1 levels.
Conclusions:
- Decreased MMPs with normal/increased TIMPs and AMG suggest matrix degradation is limited during hepatitis resolution.
- Elevated anti-inflammatory cytokines (IL-10, TGF-beta) may drive this protective mechanism.
- AMG's inhibition of MMP-1 likely plays a significant role in managing matrix remodeling in acute viral hepatitis.